click below
click below
Normal Size Small Size show me how
PHO 1
BDK
| Generic Name | Brand Name | Pharmacologic Category | Common Indication | Key Side Effects | Other Notes | US Boxed Warning | Classification |
|---|---|---|---|---|---|---|---|
| Fentanyl | Transdermal: Duragesic IV: Sublimaze | Opioid analgesic | Pain | Dizziness, Drowsiness, Nausea, Vomiting, Constipation, Pruritus, Respiratory depression (dose-related) | N/A | Potential for med. errors when converting dosage forms; use w/ CYP3A4 inhibitors (or stopping inducers) can increase concentrations; avoid exposing transdermal patch to external heat Opioid analgesic BW (see morphine IR) | CS-II |
| Hydromorphone | Dilaudid | Opioid analgesic | Pain | Dizziness, Drowsiness, Nausea, Vomiting, Constipation, Pruritus, Respiratory depression (dose-related) | N/A | Risk of medication errors w/ high-potency hydromorphone, use in opioid-tolerant patients only; Opioid analgesic BW (see morphine IR) | CS-II |
| Morphine ER | MS Contin, Kadian | Opioid analgesic | Pain | Dizziness, Drowsiness, Nausea, Vomiting, Constipation, Pruritus, Respiratory depression (dose-related) | N/A | Coingestion w/ alcohol may result in potentially fatal overdose of morphine; Opioid analgesic BW (see morphine IR) | CS-II |
| Morphine IR | IV: Duramorph, Infumorph | Opioid analgesic | Pain | Dizziness, Drowsiness, Nausea, Vomiting, Constipation, Pruritus, Respiratory depression (dose-related) | N/A | Risk of opioid addiction, leading to overdose/death; Fatal respiratory depression; Long use in pregnancy = neonatal opioid withdrawal syndrome; Use w/ benzodiazepines or CNS depressants (including alcohol) = sedation, resp. depression, coma, death | CS-II |
| Oxycodone | OxyContin, Roxicodone | Opioid analgesic | Pain | Dizziness, Drowsiness, Nausea, Vomiting, Constipation, Pruritus, Respiratory depression (dose-related) | N/A | Use w/ CYP3A4 inhibitors (or stopping inducers) can increase concentrations; Opioid analgesic BW (see morphine IR) | CS-II |
| Methadone | Dolophine | Opioid analgesic | Opioid use disorder, severe chronic pain | QTc prolongation, Dizziness, Drowsiness, Nausea, Vomiting, Constipation, Respiratory depression (dose-related) | N/A | QTc interval prolongation & serious arrhythmia (Torsades de Pointes) have occurred during treatment; Concomitant use w/ CYP3A4, 2B6, 2C19, or 2D6 (or stopping inducers) can increase concentrations Opioid analgesic BW (see morphine IR) | CS-II |
| Acetaminophen | PO/PR: Tylenol IV: Ofirmev | Non-opioid analgesic, antipyretic | Pain, fever | Nausea, Vomiting, Increased hepatic transaminases | N/A | Total daily dose from all sources shouldn't exceed max daily limit; hepatotoxicty | PO/PR: OTC |
| Tramadol | Ultram, Ultram ER | Central analgesic; partial opioid agonist | Pain | Dizziness, Drowsiness, Nausea, Vomiting, Constipation, Respiratory depression (dose-related) | Lowers seizure threshold | Resp. depression & death in children after tonsillectomy/adenoidectomy who are ultra-rapid metabolizers. Use or D/C of 3A4 inducers, inhibitors, or 2D6 inhibitors requires consideration. Risk of opioid addiction = overdose/death. (more not listed) | CS-IV |